Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Each study has a usefulness score out of 100 (rubric version 4.0). Tap a score to see what makes it up.

Highest usefulness score first. Studies without a score come last.

  1. Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Alzheimer's research & therapy 2018-08-07 Mild cognitive impairment

    The SCIENCe study confirms that SCD is a heterogeneous group, with preclinical AD and subthreshold psychiatric features.

    Why it matters

    This cohort study describes the design and first results of a study of patients with subjective cognitive decline. It found that this group is heterogeneous, with some having preclinical Alzheimer's disease and others having subthreshold psychiatric features, and that certain criteria were associated with preclinical Alzheimer's disease.

  2. Concordance between Goals of Care and Treatment Decisions for Persons with Dementia

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Journal of palliative medicine 2018-06-29 End-of-life care

    Most families chose comfort as the primary GOC.

  3. External validation of four dementia prediction models for use in the general community-dwelling population: a comparative analysis from the Rotterdam Study

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. European journal of epidemiology 2018-05-08 Long-term cohort studies

    To systematically review the literature for dementia prediction models for use in the general population and externally validate their performance in a head-to-head comparison.

    Why it matters

    This analysis externally validated four existing dementia prediction models in people aged 55 and older from the Rotterdam Study. It concerns risk prediction tools, not treating, curing or preventing Alzheimer's disease.

  4. Our results demonstrate delirium is a significant marker of mortality among seniors in the ED, and mortality risk is most salient in the first 3 months following an ED visit.

  5. Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Parkinsonism & related disorders 2018-02-09 Mild cognitive impairment

    This study provides evidence for sex differences in the progression to cognitive impairment in PD, while specific cognitive features become more important indicators of progression with impending conversion to PDD.

    Why it matters

    In Parkinson's disease, male sex was the main predictor of progressing from no cognitive impairment to mild cognitive impairment or dementia, and males progressed more rapidly than females. Among those with Parkinson's mild cognitive impairment, processing speed and working memory were associated with conversion to dementia, which may help plan care and trials.

  6. Effect of the replacement of dietary vegetable oils with a low dose of extravirgin olive oil in the Mediterranean Diet on cognitive functions in the elderly

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Journal of translational medicine 2018-01-19 Prevention trials

    We demonstrated the higher short-term improvement of cognitive functions scores in individuals of the MedDiet plus low dose of extravirgin olive oil rather than MedDiet alone.

  7. Association between palliative care and life-sustaining treatments for patients with dementia: A nationwide 5-year cohort study

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Palliative medicine 2018-01-18 End-of-life care

    Palliative care is related to reduced life-sustaining treatments for patients with dementia.

  8. This population-based study in community-dwellers aged 70 years or over suggested that multidomain intervention and n3 PUFA supplementation have not significant effects on cognitive function change in frail older adults with memory complaints.

  9. A Novel Screening Method to Identify Late-Stage Dementia Patients for Palliative Care Research and Practice

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Journal of pain and symptom management 2017-12-27 End-of-life care

    A novel method using an EHR phenotype plus brief medical record review is effective to identify hospitalized patients with late-stage dementia.

  10. Physical Activity Interventions in Preventing Cognitive Decline and Alzheimer-Type Dementia: A Systematic Review

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Annals of internal medicine 2017-12-19 Prevention and risk

    Evidence that short-term, single-component physical activity interventions promote cognitive function and prevent cognitive decline or dementia in older adults is largely insufficient.

    Why it matters

    Evidence was insufficient to conclude whether aerobic training, resistance training, or tai chi improves cognition, and low-strength evidence showed multicomponent physical activity had no effect on cognitive function. Low-strength evidence showed a multidomain intervention of physical activity, diet, and cognitive training improved several cognitive outcomes.

  11. Does Cognitive Training Prevent Cognitive Decline?: A Systematic Review

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Annals of internal medicine 2017-12-19 Prevention and risk

    In older adults with normal cognition, training improves cognitive performance in the domain trained.

    Why it matters

    This review of trials lasting at least six months found that cognitive training did not improve performance in people with mild cognitive impairment. For healthy older adults, training improved some cognitive measures, but the evidence on preventing dementia is limited.

  12. Clinicopathological correlations in behavioural variant frontotemporal dementia

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Brain : a journal of neurology 2017-12-01 Getting a diagnosis

    Patients with FTLD were distributed between FTLD-tau (34 patients: 10 corticobasal degeneration, nine progressive supranuclear palsy, eight Pick's disease, three frontotemporal dementia with parkinsonism associated with chromosome 17, three unclassifiable tauopathy, and one argyrophilic grain disease); FTLD-TDP (55 patients: nine type A including one with motor neuron disease, 27 type B including 21 with motor neuron disease, eight type C with right temporal lobe presentations, and 11 unclassifiable including eight with motor neuron disease), FTLD-FUS (eight patients), and one patient with FTLD-ubiquitin proteasome system positive inclusions (FTLD-UPS) that stained negatively for tau, TDP-43, and FUS.

    Why it matters

    This study found that the six core behavioural variant frontotemporal dementia features were similar in FTLD-tau and FTLD-TDP, so these features alone cannot separate patients by major molecular class. Data-driven classification of the 10 most common pathological diagnoses was most accurate at up to 60.2% using a combination of known predictive factors, so accurate diagnosis from clinical features remains limited.

  13. Blood pressure from mid- to late life and risk of incident dementia

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Neurology 2017-11-08 Risk factors

    Elevated blood pressure during midlife, persistence of elevated blood pressure into late life, and, among nonhypertensives, a steep decline in blood pressure during mid- to late life were associated with an increased dementia risk in a community-based cohort.

    Why it matters

    In 1,440 Framingham participants, high blood pressure in midlife and its persistence into late life were linked to higher dementia risk, and a steep drop in blood pressure among those without hypertension was also linked to higher risk. This suggests that blood pressure patterns over time may matter for dementia risk, but it did not test whether treating blood pressure prevents dementia.

  14. Assistive technology for memory support in dementia

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. The Cochrane database of systematic reviews 2017-06-11 Digital health tools

    Main results We identified no studies which met the inclusion criteria.

    Why it matters

    This systematic review identified no studies that met its inclusion criteria on assistive technology for memory support in dementia. No conclusion about benefit or harm can be drawn from it.

  15. Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Neurology 2017-06-07 Getting a diagnosis

    The Dementia with Lewy Bodies (DLB) Consortium has refined its recommendations about the clinical and pathologic diagnosis of DLB, updating the previous report, which has been in widespread use for the last decade.

    Why it matters

    This 2017 consensus report from the DLB Consortium updates its earlier, widely used criteria for diagnosing dementia with Lewy bodies. It separates clinical features from diagnostic biomarkers, gives more weight to REM sleep behavior disorder and MIBG myocardial scintigraphy, and adjusts the pathology criteria to take account of co-existing Alzheimer disease brain changes. It states that its treatment recommendations are largely based on expert opinion because randomized controlled trials in DLB are few.

  16. Cerebral Perfusion and the Risk of Dementia: A Population-Based Study

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Circulation 2017-06-06 Long-term cohort studies

    Cerebral hypoperfusion has previously been associated with mild cognitive impairment and dementia in various cross-sectional studies, but whether hypoperfusion precedes neurodegeneration is unknown.

    Why it matters

    This study measured blood flow in the brain and then followed participants to see who developed dementia, to test whether reduced blood flow comes before cognitive decline. If poor brain perfusion precedes dementia, it could be a target for prevention, but this study only examined the association over time.

  17. Fasting lipid fractions (triglycerides [TGs], high-density lipoprotein cholesterol [HDL-C], low-density lipoprotein cholesterol [LDL-C], total cholesterol [TC]) were studied as continuous variables, and results are reported per SD increase of each lipid fraction.

    Why it matters

    In this cohort, higher LDL cholesterol and total cholesterol were linked to higher Alzheimer risk, but the link weakened after accounting for APOE epsilon4. Triglycerides and HDL cholesterol were not linked to dementia risk after accounting for vascular risk factors.

  18. Interactive wearable systems for upper body rehabilitation: a systematic review

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Journal of neuroengineering and rehabilitation 2017-03-11 Treatments

    This review has shown that wearable systems are used mostly for the monitoring and provision of feedback on posture and upper extremity movements in stroke rehabilitation.

    Why it matters

    This review is about wearable systems for upper body rehabilitation, mostly in stroke rehabilitation, and does not address treating, curing, or preventing Alzheimer's disease. Only three of the included studies conducted clinical trials, including one randomized clinical trial.

  19. A systematic review of medication non-adherence in persons with dementia or cognitive impairment

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. PloS one 2017-02-06 Caregiving

    Fifteen studies met inclusion criteria.

    Why it matters

    This systematic review of community-dwelling people with cognitive impairment or dementia found that new-learning, memory, and executive functioning were associated with improved medication adherence and were the focus of most studies. It extracted data on adherence factors and strategies to improve medication adherence, comparing them with cognitively intact populations when available.

  20. Earlier Goals of Care Discussions in Hospitalized Terminally Ill Patients and the Quality of End-of-Life Care: A Retrospective Study

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. The American journal of hospice & palliative care 2016-12-13 End-of-life care

    Later GOCDs were associated with greater risk of aggressive interventions and death as an inpatient and greater odds of ICU admission.

  21. Adherence to a Mediterranean-Style Diet and Effects on Cognition in Adults: A Qualitative Evaluation and Systematic Review of Longitudinal and Prospective Trials

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Frontiers in nutrition 2016-07-22 Prevention trials

    The Mediterranean-style diet (MedDiet) involves substantial intake of fruits, vegetables, and fish, and a lower consumption of dairy, red meat, and sugars.

  22. Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. PloS one 2016-04-28 Clinical safety

    These studies show that remote physical activity monitoring is feasible in neurological diseases, including in people with moderate to severe neurological disability.

  23. Effectiveness of interventions to directly support food and drink intake in people with dementia: systematic review and meta-analysis

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. BMC geriatrics 2016-01-22 Clinical safety

    We found no definitive evidence on effectiveness, or lack of effectiveness, of specific interventions but studies were small and short term.

  24. Depression and frailty in later life: a systematic review

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Clinical interventions in aging 2015-12-15 Clinical safety

    Frailty and depression are important issues affecting older adults.

  25. Tools to Promote Shared Decision Making in Serious Illness: A Systematic Review

    ✓ Peer-reviewed alzhub usefulness score 67 out of 100. JAMA internal medicine 2015-07-01 End-of-life care

    Seventeen randomized clinical trials tested decision tools in serious illness.

From across this topic

9 of the 7,967 studies in this topic, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.

Other topics